As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5:11pm† Annovis Bio, Inc.                 10-Q        3/31/24   57:4M                                     Toppan Merrill Bridge/FA 
  5/9/24  Annovis Bio, Inc.                 8-K:7,9      5/9/24   11:201K                                   Toppan Merrill/FA        
  5/6/24  Annovis Bio, Inc.                 DEFA14A                1:25K                                    Toppan Merrill/FA        
  5/6/24  Annovis Bio, Inc.                 8-K:7,9      5/6/24   11:209K                                   Toppan Merrill/FA        
  5/2/24  Annovis Bio, Inc.                 8-K:8,9      5/2/24   11:177K                                   Toppan Merrill Bridge/FA 
  5/1/24  Annovis Bio, Inc.                 8-K:5,9      5/1/24   11:281K                                   Toppan Merrill/FA        
  5/1/24  Annovis Bio, Inc.                 424B5                  1:484K                                   Toppan Merrill/FA        
 4/29/24  Annovis Bio, Inc.                 ARS        12/31/23    1:1.9M                                   Toppan Merrill/FA        
 4/29/24  Annovis Bio, Inc.                 DEFA14A                1:1.9M                                   Toppan Merrill/FA        
 4/29/24  Annovis Bio, Inc.                 DEF 14A     6/12/24    1:1.2M                                   Toppan Merrill/FA        
 4/26/24  Annovis Bio, Inc.                 8-K:1,9     4/25/24   12:943K                                   Toppan Merrill/FA        
  4/3/24‡ Annovis Bio, Inc.                 8-K:2,9      4/2/24   11:225K                                   Toppan Merrill/FA        
 3/29/24  Annovis Bio, Inc.                 10-K       12/31/23   68:6.9M                                   Toppan Merrill Bridge/FA 
 3/22/24  Annovis Bio, Inc.                 8-K:8       3/22/24   10:188K                                   Toppan Merrill/FA        
 3/22/24‡ Annovis Bio, Inc.                 424B5       3/21/24    1:397K                                   Toppan Merrill/FA        
 3/21/24  Annovis Bio, Inc.                 8-K:1,9     3/21/24   11:498K                                   Toppan Merrill/FA        
 3/20/24  Annovis Bio, Inc.                 8-K:7,9     3/20/24   11:201K                                   Toppan Merrill/FA        
 3/20/24‡ Annovis Bio, Inc.                 8-K:8       3/19/24   10:188K                                   Toppan Merrill/FA        
 3/19/24‡ Annovis Bio, Inc.                 424B5                  1:472K                                   Toppan Merrill/FA        
 3/19/24‡ Annovis Bio, Inc.                 424B5                  1:472K                                   Toppan Merrill/FA        

____________
†	The Filing’s time of SEC acceptance (U.S. Eastern Time).  The SEC’s Filings System is “open” Monday through Friday from 6am to 10pm ET. Because the SEC “closes” at 5:30pm ET, most subsequently-accepted Filings won’t be released to the public until sometime after 6am ET the next day.
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	424B5	Prospectus – Primary Offering or Shelf Securities – New Facts or Events.
	ARS	Annual Report to Security Holders.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	DEFA14A	Definitive Additional Proxy Soliciting Material — Schedule 14A.